World Health Organization bids adieu to Hans Hogerzeil – The dynamic Director of Essential Medicines and Pharmaceutical Policies
B. Gitanjali1★★ Corresponding author
- 1et al. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. JAMA 2001;286:2011-4.
CORRESPONDENCE
B. Gitanjali
et al. Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine. JAMA 2001;286:2011-4.
Volume 2, Issue 4 · pp. 308–309 · PUBLISHED 2011 · DOI: 10.4103/0976-500X.85943
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
On May 31, 2011, Hans Hogerzeil, Director of Essential Medicines and Pharmaceutical Policies, World Health Organization (WHO), Geneva, received a touching sendoff from the staff and colleagues of WHO, an agency which he had served for 26 years. Hans received his medical degree from the University of Leiden, The Netherlands, and spent his early years as a doctor in India, working in a leprosy mission hospital, and later in a hospital in Ghana, Africa. Hans joined the WHO’s Regional Offi ce for the Eastern Mediterranean (EMRO) in Alexandria, Egypt, in 1985 and worked with Prof. Ranjit Roy Chaudhury for a few years. Later, he joined the WHO Action Programme on Essential Drugs at the WHO headquarters in Geneva and went on to become the Director of Essential Medicines and Pharmaceutical Policies. Hans played a vital role in building on and strengthening the edifi ce built by stalwarts of the essential drugs movement, like Mahler, Lauridsen and Helling-Borda. Hans is well known in India for his book “A guide to good prescribing”, which has been translated into many languages, and its sister publication, “A teacher’s guide to good prescribing”.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Gitanjali, B. (2011). World Health Organization bids adieu to Hans Hogerzeil – The dynamic Director of Essential Medicines and Pharmaceutical Policies. Journal of Pharmacology and Pharmacotherapeutics, 2(4), 308–309. https://doi.org/10.4103/0976-500X.85943
